Biotechnology News XYREM Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-3 out of 3 found

Current Search: xyrem: 3

Off-Label Promotion Under Scrutiny by DOJ
In a continuing shift of enforcement strategy, the U.S.

Department of Justice (DOJ) has firmly taken control of off-label use allegations against pharmaceutical, biotechnology, and medical device manufacturers.

Various U.S.

attorneys...

Genetic Engineering News: Jun 1 2008 6:59PM
Matching: xyrem

Find similar documents

Off-Label Promotion Under Scrutiny by DOJ
In a continuing shift of enforcement strategy, the U.S.

Department of Justice (DOJ) has firmly taken control of off-label use allegations against pharmaceutical, biotechnology, and medical device manufacturers.

Various U.S.

attorneys...

Genetic Engineering News: May 31 2008 5:41PM
Matching: xyrem

Find similar documents

Jazz Pharmaceuticals 1Q net loss widens, revenue misses estimates
NEW YORK (Thomson Financial) - Jazz Pharmaceuticals Inc.

reported late Tuesday its first-quarter net loss widened to $46.7 million from $19.6 million in the same period a year earlier.

Per-share loss for the quarter ended March 31 was $1...

Sharewatch: May 13 2008 9:11PM
Matching: xyrem

Find similar documents

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright � 1997-2008 - BioPortfolio Limited.